Trial · NCT03012672
Adverse events120
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 120
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Acute Kidney Injury | Renal and urinary disorders | ARM I (HIGHER-DOSE): | 1 | 20 | 2 |
| other | Acute Kidney Injury | Renal and urinary disorders | ARM II (LOWER-DOSE): | 2 | 30 | 2 |
| other | Alkalosis | Metabolism and nutrition disorders | ARM I (HIGHER-DOSE): | 1 | 20 | 1 |
| other | Alkalosis | Metabolism and nutrition disorders | ARM II (LOWER-DOSE): | 0 | 30 | 0 |
| other | Anorexia | Metabolism and nutrition disorders | ARM I (HIGHER-DOSE): | 1 | 20 | 1 |
| other | Anorexia | Metabolism and nutrition disorders | ARM II (LOWER-DOSE): | 1 | 30 | 1 |
| other | Atrial Fibrillation | Cardiac disorders | ARM I (HIGHER-DOSE): | 2 | 20 | 3 |
| other | Atrial Fibrillation | Cardiac disorders | ARM II (LOWER-DOSE): | 1 | 30 | 1 |
| other | Bacteremia | Infections and infestations | ARM I (HIGHER-DOSE): | 5 | 20 | 5 |
| other | Bacteremia | Infections and infestations | ARM II (LOWER-DOSE): | 4 | 30 | 6 |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | ARM I (HIGHER-DOSE): | 1 | 20 | 1 |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | ARM II (LOWER-DOSE): | 1 | 30 | 1 |
| other | Blood Clot, Right Ear | Ear and labyrinth disorders | ARM I (HIGHER-DOSE): | 0 | 20 | 0 |
| other | Blood Clot, Right Ear | Ear and labyrinth disorders | ARM II (LOWER-DOSE): | 1 | 30 | 1 |
| other | Edema Limbs, Volume Overload | Cardiac disorders | ARM I (HIGHER-DOSE): | 2 | 20 | 2 |
| other | Edema Limbs, Volume Overload | Cardiac disorders | ARM II (LOWER-DOSE): | 2 | 30 | 2 |
| other | Epistaxis | Blood and lymphatic system disorders | ARM I (HIGHER-DOSE): | 0 | 20 | 0 |
| other | Epistaxis | Blood and lymphatic system disorders | ARM II (LOWER-DOSE): | 2 | 30 | 2 |
| other | Febrile Neutropenia | Blood and lymphatic system disorders | ARM I (HIGHER-DOSE): | 9 | 20 | 10 |
| other | Febrile Neutropenia | Blood and lymphatic system disorders | ARM II (LOWER-DOSE): | 15 | 30 | 21 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03012672/events